Hematopoietic stem cell transplantation (HSCT)-associated thrombotic microangiopathy (TA-
TMA) is now a well-recognized and potentially severe complication of HSCT that carries a …

Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA)
remains a difficult complication to address due to its high mortality rate, lack of standard …

Abstract Background and Objectives There are no widely accepted criteria for the definition
of hematopoietic stem cell transplant-associated microangiopathy (TAM). An International …

Background. The lack of an accepted definition of transplantation-associated thrombotic
microangiopathy (TMA) has led the Blood and Marrow Transplants Clinical Trials Network …

Schistocytes are fragments of red blood cells (RBCs) produced by extrinsic mechanical
damage within the circulation. The detection of schistocytes is an important morphological …

Transplant‐associated thrombotic microangiopathy (TA‐TMA) is a complication of
allogeneic transplantation (allo‐HCT). The incidence and risk factors associated with TA …

Transplantation-associated thrombotic microangiopathy (TA-TMA) is an infrequent but
devastating syndrome that occurs in allogeneic hematopoietic stem cell transplant …

Background and objectives: Thrombotic microangiopathy (TMA) is a known complication of
hematopoietic cell transplantation (HCT). The etiology and diagnosis of TMA in this patient …

Background. Thrombotic microangiopathy (TMA) has been described as severe
complication after hematopoietic stem cell transplantation (HSCT). The principal aim of this …

Transplant-associated thrombotic microangiopathy (TA-TMA) remains a major complication
of allogeneic hematopoietic stem cell transplantation (allo-HSCT). We hypothesized that TA …